Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute generalized exanthematous pustulosis induced by hydroxychloroquine: Three cases and a review of the literature Paradisi, Andrea
2008
30 Supplement 3 p. 930-940
11 p.
artikel
2 Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study Pellicelli, Adriano M.
2008
30 Supplement 3 p. 317-323
7 p.
artikel
3 Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation Lewiecki, E. Michael
2008
30 Supplement 3 p. 605-621
17 p.
artikel
4 Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: Results of a retrospective study of an electronic medical-records database in the United States, 2002–2006 Luo, Weixiu

30 Supplement 3 p. 2423-2435
artikel
5 Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database Jackson II, Kenneth C.
2008
30 Supplement 3 p. 1558-1563
6 p.
artikel
6 Ambrisentan for the management of pulmonary arterial hypertension Cheng, Judy W.M.
2008
30 Supplement 3 p. 825-833
9 p.
artikel
7 Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: A prospective, randomized, open-label, blinded end-point trial Hermida, Ramón C.
2008
30 Supplement 3 p. 108-120
13 p.
artikel
8 Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study Emery, Paul
2008
30 Supplement 3 p. 70-83
14 p.
artikel
9 Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: A post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial Lewin, Andrew J.

30 Supplement 3 p. 2354-2365
artikel
10 A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure Pierce, Dwayne A.
2008
30 Supplement 3 p. 1681-1684
4 p.
artikel
11 A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations Robles, Gisela I.
2008
30 Supplement 3 p. 800-812
13 p.
artikel
12 Assessing retinol stability in a hydroquinone 4%/retinol 0.3% cream in the presence of antioxidants and sunscreen under simulated-use conditions: a pilot study Akhavan, Arash
2008
30 Supplement 3 p. 543-547
5 p.
artikel
13 A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit Brophy, Gretchen M.

30 Supplement 3 p. 2324-2334
artikel
14 A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes Hollander, Priscilla
2008
30 Supplement 3 p. 1976-1987
12 p.
artikel
15 A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a β-blocker on blood pressure reduction Wald, David S.
2008
30 Supplement 3 p. 2030-2039
10 p.
artikel
16 Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: A meta-analysis Sobieraj, Diana M.
2008
30 Supplement 3 p. 1416-1425
10 p.
artikel
17 Bioavailability of Two Single-Dose Oral Formulations of Omeprazole 20 mg: An Open-Label, Randomized Sequence, Two-Period Crossover Comparison in Healthy Mexican Adult Volunteers Poo, Jorge Luis
2008
30 Supplement 3 p. 693-699
7 p.
artikel
18 Bioequivalence and comparison of pharmacokinetic properties of 4-mg tablet formulations of rosiglitazone hydrochloride and rosiglitazone maleate: A single-dose, randomized, open-label, two-period crossover study in healthy adult male Chinese volunteers Yu, Jia

30 Supplement 3 p. 2272-2279
artikel
19 Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy chinese adult male volunteers: a randomized sequence, open-label, two-period crossover study Zou, Jian-Jun
2008
30 Supplement 3 p. 1651-1657
7 p.
artikel
20 Bioequivalence of two formulations of ketotifen fumarate ophthalmic solution: A single-center, randomized, double-masked conjunctival allergen challenge investigation in allergic conjunctivitis Torkildsen, Gail L.
2008
30 Supplement 3 p. 1272-1282
11 p.
artikel
21 Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: A single-dose, randomized, open-label, crossover study Di Girolamo, Guillermo
2008
30 Supplement 3 p. 2015-2023
9 p.
artikel
22 Biomarkers for Pompe Disease Maire, Irène
2008
30 Supplement 3 p. S4-S5
2 p.
artikel
23 Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis Massarotti, Elena M.
2008
30 Supplement 3 p. 429-442
14 p.
artikel
24 Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: A two-way crossover study in healthy young adults Reiz, Joseph L
2008
30 Supplement 3 p. 59-69
11 p.
artikel
25 Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study Bonnet, Jacques

30 Supplement 3 p. 2298-2313
artikel
26 Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults Kivitz, Alan

30 Supplement 3 p. 2366-2377
artikel
27 Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: A 9-month, prospective, randomized, open-label, blinded-evaluation trial Barrios, Vivencio
2008
30 Supplement 3 p. 98-107
10 p.
artikel
28 Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: Economic analysis of the aggressive lipid-lowering initiation abates new cardiac events (ALLIANCE) study Mullins, C. Daniel
2008
30 Supplement 3 p. 2204-2216
13 p.
artikel
29 Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration Hernandez-Pastor, Luis Javier

30 Supplement 3 p. 2436-2451
artikel
30 Cough induced by losartan with resolution after substitution with enalapril Dashti-Khavidaki, Simin
2008
30 Supplement 3 p. 548-551
4 p.
artikel
31 Current target ranges of mycophenolic acid exposure and drug-related adverse events: A 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients Kuypers, Dirk R.J.
2008
30 Supplement 3 p. 673-683
11 p.
artikel
32 Dear Dr. Walson Porath, Adam D.
2008
30 Supplement 3 p. 1934-
1 p.
artikel
33 Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer Nozawa, Hiroaki
2008
30 Supplement 3 p. 1160-1165
6 p.
artikel
34 Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: An 18-week, single-center, dose-escalating, prospective, open-label study Cubo, Esther
2008
30 Supplement 3 p. 182-189
8 p.
artikel
35 Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching Akazawa, Manabu
2008
30 Supplement 3 p. 1003-1016
14 p.
artikel
36 Effect of levetiracetam on cardiac repolarization in healthy subjects: A single-dose, randomized, placebo- and active-controlled, four-way crossover study Hulhoven, Réginald
2008
30 Supplement 3 p. 260-270
11 p.
artikel
37 Effect of nicotine lozenges on affective smoking withdrawal symptoms: Secondary analysis of a randomized, double-blind, placebo-controlled clinical trial Shiffman, Saul
2008
30 Supplement 3 p. 1461-1475
15 p.
artikel
38 Effects of aminaftone 75 mg TID on soluble adhesion molecules: A 12-week, randomized, open-label pilot study in patients with systemic sclerosis Scorza, Raffaella
2008
30 Supplement 3 p. 924-929
6 p.
artikel
39 Effects of Carvedilol on Left Ventricular Function and Oxidative Stress in Infants and Children with Idiopathic Dilated Cardiomyopathy: A 12-Month, Two-Center, Open-Label Study Bajcetic, Milica
2008
30 Supplement 3 p. 702-714
13 p.
artikel
40 Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: Two clinical trials in healthy volunteers and patients with hereditary angioedema Birjmohun, Rakesh S.

30 Supplement 3 p. 2314-2323
artikel
41 Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: A meta-analysis of eight randomized, placebo-controlled, 12-week trials Rahimi, Roja
2008
30 Supplement 3 p. 884-901
18 p.
artikel
42 Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug—naive patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, parallel-group study Moretto, Thomas J.
2008
30 Supplement 3 p. 1448-1460
13 p.
artikel
43 Efficacy of combination intravenous lidocaine and dexamethasone on propofol injection pain: A randomized, double-blind, prospective study in adult korean surgical patients Kwak, Kyung-Hwa
2008
30 Supplement 3 p. 1113-1119
7 p.
artikel
44 Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study Chancellor, Michael B.
2008
30 Supplement 3 p. 1766-1781
16 p.
artikel
45 Emergency hospital admissions after income-based deductibles and prescription copayments in older users of inhaled medications Dormuth, Colin R.
2008
30 Supplement 3 p. 1038-1050
13 p.
artikel
46 Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: A single-center, single-blind, six-period crossover study in healthy female subjects Perkins, Alan C.
2008
30 Supplement 3 p. 834-844
11 p.
artikel
47 Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: Selected reports from working groups Giacoia, George P.
2008
30 Supplement 3 p. 2097-2101
5 p.
artikel
48 Foreword Germain, Dominique P.
2008
30 Supplement 3 p. S75-S76
2 p.
artikel
49 Foreword Desnuelle, Claude
2008
30 Supplement 3 p. S1-
1 p.
artikel
50 Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia Merchant, Sanjay
2008
30 Supplement 3 p. 717-733
17 p.
artikel
51 Hydroxyurea associated with concomitant occurrence of diffuse longitudinal melanonychia and multiple squamous cell carcinomas in an elderly subject Saraceno, Rosita
2008
30 Supplement 3 p. 1324-1329
6 p.
artikel
52 Implications of early renal changes in fabry disease Mauer, Michael
2008
30 Supplement 3 p. S40-
1 p.
artikel
53 Infliximab and methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis of dosage regimens Zintzaras, Elias
2008
30 Supplement 3 p. 1939-1955
17 p.
artikel
54 In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature Nedergaard, Hanne
2008
30 Supplement 3 p. 1309-1315
7 p.
artikel
55 In vitro stability of two formulations of recombinant activated factor viia reconstituted in inappropriate solvents or at inappropriate volumes Petersson, Britt
2008
30 Supplement 3 p. 917-923
7 p.
artikel
56 Ixabepilone: A novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer Steinberg, Michael
2008
30 Supplement 3 p. 1590-1617
28 p.
artikel
57 Lapatinib: A dual inhibitor of human epidermal growth factor receptor tyrosine kinases Medina, Patrick J.
2008
30 Supplement 3 p. 1426-1447
22 p.
artikel
58 Long-term persistence with statin therapy: A nationwide register study in Finland Helin-Salmivaara, Arja
2008
30 Supplement 3 p. 2228-2240
13 p.
artikel
59 Maraviroc: A CCR5-receptor antagonist for the treatment of HIV-1 infection Lieberman-Blum, Sharon S.
2008
30 Supplement 3 p. 1228-1250
23 p.
artikel
60 Meta-Analysis of 13 Randomized Controlled Trials Comparing Bimatoprost with Latanoprost in Patients with Elevated Intraocular Pressure Cheng, Jin-Wei
2008
30 Supplement 3 p. 622-632
11 p.
artikel
61 Metronomic etoposide/cyclophosphamide/celecoxib regimen given to children and adolescents with refractory cancer: A preliminary monocentric study André, Nicolas
2008
30 Supplement 3 p. 1336-1340
5 p.
artikel
62 Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial Clauw, Daniel J.
2008
30 Supplement 3 p. 1988-2004
17 p.
artikel
63 Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia DeRemer, David L.
2008
30 Supplement 3 p. 1956-1975
20 p.
artikel
64 Ocular comfort and drying effects of three topical antihistamine/mast cell stabilizers in adults with allergic conjunctivitis: A randomized, double-masked crossover study Torkildsen, Gail L.
2008
30 Supplement 3 p. 1264-1271
8 p.
artikel
65 Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: The FS-TOO resource utilization substudy Mauldin, Patrick D.
2008
30 Supplement 3 p. 1553-1557
5 p.
artikel
66 Oral versus injectable antipsychotic treatment in early psychosis: Post hoc comparison of two studies Emsley, Robin

30 Supplement 3 p. 2378-2386
artikel
67 Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia Fowler, Jill A.
2008
30 Supplement 3 p. 231-248
18 p.
artikel
68 Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among texas medicaid recipients Cheong, Chelim
2008
30 Supplement 3 p. 1893-1907
15 p.
artikel
69 Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting Yaldo, Avin Z.

30 Supplement 3 p. 2452-2460
artikel
70 Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: A phase I, open-label, dose-escalation clinical study Burge, Daniel J.
2008
30 Supplement 3 p. 1806-1816
11 p.
artikel
71 Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study Solans, Anna
2008
30 Supplement 3 p. 1639-1650
12 p.
artikel
72 Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes Covington, Paul
2008
30 Supplement 3 p. 499-512
14 p.
artikel
73 Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002 Frei, Christopher R.

30 Supplement 3 p. 2335-2341
artikel
74 Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: An open-label, parallel-group study Martin, David E.
2008
30 Supplement 3 p. 1794-1805
12 p.
artikel
75 Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study Christrup, Lona L.
2008
30 Supplement 3 p. 469-481
13 p.
artikel
76 Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: A randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects Gordi, Toufigh
2008
30 Supplement 3 p. 909-916
8 p.
artikel
77 Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers Cheng, Yi-Fang

30 Supplement 3 p. 2342-2353
artikel
78 Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study Zhang, Wei
2008
30 Supplement 3 p. 1283-1289
7 p.
artikel
79 Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry Liu, Ming-Yan
2008
30 Supplement 3 p. 641-653
13 p.
artikel
80 Practical management of cutaneous reactions to the methylphenidate transdermal system: Recommendations from a dermatology expert panel consensus meeting Warshaw, Erin M.
2008
30 Supplement 3 p. 326-337
12 p.
artikel
81 Prolonged intrahepatic cholestasis after exposure to loxoprofen Ichikawa, Takeshi

30 Supplement 3 p. 2402-2406
artikel
82 Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: Post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect Mini, Louis
2008
30 Supplement 3 p. 1316-1323
8 p.
artikel
83 Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10 week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers Shiffman, Saul
2008
30 Supplement 3 p. 1852-1858
7 p.
artikel
84 Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis Cotté, François-Emery

30 Supplement 3 p. 2410-2422
artikel
85 Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications Farley, Joel F.
2008
30 Supplement 3 p. 1524-1539
16 p.
artikel
86 Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction Sun, Shawn X.
2008
30 Supplement 3 p. 2217-2227
11 p.
artikel
87 Review of recent results of montelukast use as a monotherapy in children with mild asthma Wahn, Ulrich
2008
30 Supplement 3 p. 1026-1035
10 p.
artikel
88 Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: A retrospective, nested case-controlled analysis Mohr III, John F.
2008
30 Supplement 3 p. 152-157
6 p.
artikel
89 Risk of discontinuation of risperidone after exposure to potentially interacting drugs: A nested case-control study in patients with schizophrenia Ishak, K. Jack
2008
30 Supplement 3 p. 1251-1263
13 p.
artikel
90 Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: A 28-day, open-label study Mathew, Sanjay J.
2008
30 Supplement 3 p. 1658-1666
9 p.
artikel
91 Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers Smith, Kevin
2008
30 Supplement 3 p. 2051-2068
18 p.
artikel
92 Six-month, prospective, longitudinal, open-Label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement Kennedy, Mary Jayne
2008
30 Supplement 3 p. 1687-1699
13 p.
artikel
93 Stability of doripenem in vitro in representative infusion solutions and infusion bags Psathas, Petros A.
2008
30 Supplement 3 p. 2075-2087
13 p.
artikel
94 Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan Kobeissy, Abdallah
2008
30 Supplement 3 p. 1408-1415
8 p.
artikel
95 The economics of pediatric formulation development for off-patent drugs Milne, Christopher-Paul
2008
30 Supplement 3 p. 2133-2145
13 p.
artikel
96 The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study Esnault, Vincent L.M.
2008
30 Supplement 3 p. 482-498
17 p.
artikel
97 The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: A cross-sectional exploratory study Morrens, Manuel
2008
30 Supplement 3 p. 684-692
9 p.
artikel
98 Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study Hurwitz, Barrie J.
2008
30 Supplement 3 p. 1102-1112
11 p.
artikel
99 Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy Ben-Menachem, Elinor
2008
30 Supplement 3 p. 1180-1195
16 p.
artikel
100 Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis Tang, Boxiong
2008
30 Supplement 3 p. 1375-1384
10 p.
artikel
101 Two single-center, double-blind, randomized, placebo-controlled, phase i studies to investigate the tolerability and pharmacokinetics of ch-1504, an antifolate, in healthy male subjects Mant, Tim
2008
30 Supplement 3 p. 131-142
12 p.
artikel
102 Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: Results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007 Dowzicky, Michael J.
2008
30 Supplement 3 p. 2040-2050
11 p.
artikel
103 Use of glargine in pregnant women with Type 1 diabetes mellitus: A case-control study Imbergamo, Maria P.
2008
30 Supplement 3 p. 1476-1484
9 p.
artikel
104 Use of urinary globotriaosylceramide for fabry disease screening in Canada Auray-Blais, Christiane
2008
30 Supplement 3 p. S79-S80
2 p.
artikel
                             104 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland